Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has informed stock exchanges about its upcoming schedule of meetings with analysts and institutional investors, as required under SEBI Listing Regulations. Three sessions are lined up: the Goldman Sachs Global CDMO Day in Singapore on September 16-17, 2025, followed by investor meetings in Singapore on September 18, and the Kotak Healthcare Forum 2025 in Mumbai on September 19. All meetings will be held in person and may include group as well as one-on-one interactions. The company has noted that dates are subject to change depending on exigencies. This is a routine compliance disclosure with no new financial or business information.
This is a standard regulatory filing and does not, by itself, carry material impact on the stock price or shareholder value. Investors may watch these meetings for any incremental commentary on business strategy or growth outlook, but no specific guidance is being shared here.